Conferences and symposiums

Frontiers in Cancer Research and Therapy 2018

2018-03-0808:45 to 2018-03-0916:30 Nobel Forum, Nobels väg 1Campus Solna

Thursday, 8 March

8.30
Morning Coffee

8.45-9.00
Welcome
Lars Holmgren, Acting Head of Department of Oncology-Pathology

SESSION 1: Cancer Microbiome

Chairs: Charlotte Rolny + Johan Hartman

9.00-9.30
Fiona Powrie, The Kennedy Institute of Rheumatology
Title: Inflammation driven cancer: Host and microbial pathways

9.30-10.00
Sebastian Zeissig, Technical University Dresden
Title: Myeloid control of anti-tumor immunity in colorectal cancer

10.00-10.30
Giorgio Trinchieri, National Institutes of Health
Title: Microbiome: Carcinogenesis and Cancer Therapy

10.30-11.00 Coffee Break

11.00-11.30
Jennifer Wargo, MD Anderson Cancer Center
Title: The Microbiome and Response to Cancer Therapy

11.30-12.00
Arthur Mortha, University of Toronto
Title: Intestinal immune regulation through host-microbiome interactions

12.00-13.00 Lunch & poster session

SESSION 2: Molecular Imaging of Tumor Treatment Responses 

Chairs: Kristina Viktorsson + Thuy Tran

13.00-13.30
Brian Pogue, Thayer School of Engineering at Dartmouth
Title: Molecular guided surgery with fluorescent affibody molecules

13.30-14.00
Jason Lewis, Memorial Sloan Kettering Cancer Center
Title: Imaging Serum Biomarkers

14.00-14.30
Marika Nestor, Uppsala University
Title: Precision imaging using PET/SPECT: preclinical studies on the use of radiolabeled cancer targeting agents for potential use in tumor characterisation, patient stratification and treatment response monitoring

14.30-15.00 Coffee Break

SESSION 3a: Novel Therapies

Chairs: Andreas Lundqvist, Päivi Östling

15.00-15.30
Per Hydbring, Karolinska Institutet
Title: MicroRNA therapy as a viable option against refractory cancer

15.30-16.00
Sonia Lain, Karolinska Institutet
Title: From phenotypic screens to the structure of a small molecule bound to its target, and the challenges beyond

16.00-16.30
Timothy Chan, Memorial Sloan Kettering Cancer Center
Title: Immunotherapy:  Evolving landscape of mechanisms and biomarkers

16.30-17.00
Ana Anderson, Harvard Medical School
Title: Immunogenomics, novel checkpoint receptors, and understanding the CD8+ T cell response in cancer

Friday, 9 March

8.30-9.00 Morning Coffee

SESSION 3b: Novel Therapies

Chairs: Jonas Mattsson + Marianne Farnebo

9.00-9.30
Jonas Bergh, Karolinska Institutet
Title: Breast cancer is an array of diseases with different characteristics in the metastatic setting

9.30-10.00
Rakesh K. Jain, Harvard Medical School
Title: Reengineering the tumor microenvironment to improve cancer treatment: Bench to bedside

10.00-10.30 Coffee Break

10.30-11-00
Michel Sadelain, Memorial Sloan Kettering Cancer Center
Title: Chimeric antigen receptor (CAR) therapy

11.00-11.30
Kevin V. Morris, Beckman Research Institute
Title: RNA mediated gene editing in cell selection and the evolution of cancer

11.30-11.45
In memoriam Dan Grandér, Stefan Einhorn

11.45-13.00 Lunch & poster session

SESSION 4: Therapy Resistance and Precision Oncology

Chairs: Thomas Helleday + Ingemar Ernberg

13.00-13.30
Olli Kallioniemi, Karolinska Institutet
Title: Precision systems cancer medicine

13.30-14.00
Pierre Close, University of Liège
Title: Translation regulation through wobble tRNA modification in cancer

14.00-14.30
Sham Mailankody, Memorial Sloan Kettering Cancer Center
Title: Precision Oncology: Clinical Promise and Regulatory Challenges

14.30-14.45 Coffe Break

14.45-15.15
Gregory Riely, Memorial Sloan Kettering Cancer Center
Title: Approaches to understanding and overcoming resistance to targeted therapies in lung cancer

15.15-15.45
Sydney Shaffer, University of Pennsylvania
Title: Cellular memory and rare cell variability in cancer

15.45-16.15
John Hickman, Independent, Paris
Title: The limits of medicine in the treatment of advanced cancers: possible future directions

16.15-16.45
Panel discussion

16.45
Closing words and awards, Lars Holmgren, Acting Head of Department of Oncology-Pathology

NB! No registration required, seats are limited, please be on time 

Contact person: Hanna Sillén